Delivery Order SPE2DB24D1021-SPE2DB25FEUFX

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $11,624.16 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024, with a completion date of December 13, 2024. This is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
This federal contract award is for the delivery of the TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine to the Defense Logistics Agency (DLA). The $1,368.40 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 9, 2024, with a completion date of May 10, 2024. The contract is under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $73,379.65 and an ultimate completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,174.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order placed under an existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $1,937.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of December 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,498.76 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of April 30, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $1,194.09 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The award does not have a set-aside designation. This contract supports the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $1,771.40 for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed price arrangement. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $6,794.88, is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The contract has a period of performance through December 31, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $41,873.67, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 26, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEUFX
    Delivery Order

The federal contract award is for the provision of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to the Defense Logistics Agency (DLA). The $1,396.08 firm fixed price delivery order has an ultimate completion date of February 27, 2025 and was awarded on February 26, 2025 to the prime contractor, Amerisourcebergen Drug Corp. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing a range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 11:07 AM